Produk

Sandoo minangka Ketorolac Trometamol, Olopatadine Hydrochloride, Vancomycin Hydrochloride produsen lan pemasok sing apik ing China. Pabrik kita wis fokus ing API, anti-kanker, intermediet obat antivirus, bahan kimia sing apik, ekspor lan impor aditif panganan luwih saka 10 taun, lan produk kita nutupi kabeh ndonya, kayata Amerika Serikat, Kanada, Inggris. , Prancis, lsp., lan mboko sithik nutupi luwih saka 20 negara ing saindenging jagad.
View as  
 
Asam benzoat 5-metil-2-(triazol-2-yl).

Asam benzoat 5-metil-2-(triazol-2-yl).

Jeneng produk: 5-metil-2-(triazol-2-yl)asam benzoat
Formula Molekul: C10H9N3O2
Bobot Molekul: 203.2
Nomer Registrasi CAS: 956317-36-5

Waca liyaneKirim Pitakonan
cis-5-Norbornene-exo-2,3-dikarboksilat anhidrida

cis-5-Norbornene-exo-2,3-dikarboksilat anhidrida

Jeneng produk: cis-5-Norbornene-exo-2,3-dicarboxylic anhydride
Formula Molekul: C9H8O3
Bobot Molekul: 164.16
Nomer Registrasi CAS: 2746-19-2

Waca liyaneKirim Pitakonan
(R,R)-1,2-bis(methanesulfonyloxymethyl)sikloheksana

(R,R)-1,2-bis(methanesulfonyloxymethyl)sikloheksana

Jeneng Produk:(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
Formula Molekul: C10H20O6S2
Bobot Molekul: 300.39
Nomer Registrasi CAS: 186204-35-3

Waca liyaneKirim Pitakonan
(1R,2R)-1,2-Cyclohexanedimethanol

(1R,2R)-1,2-Cyclohexanedimethanol

Jeneng produk:(1R,2R)-1,2-Cyclohexanedimethanol
Formula Molekul: C8H16O2
Bobot Molekul: 144.21
Nomer Registrasi CAS: 65376-05-8

Waca liyaneKirim Pitakonan
(1R,2R)-1,2-Asam sikloheksanedikarboksilat

(1R,2R)-1,2-Asam sikloheksanedikarboksilat

Jeneng produk:(1R,2R)-1,2-Asam sikloheksanedikarboksilat
Formula Molekul: C8H12O4
Bobot Molekul: 172.18
Nomer Registrasi CAS: 46022-05-3

Waca liyaneKirim Pitakonan
Lurasidone hidroklorida

Lurasidone hidroklorida

Jeneng produk: Lurasidone hydrochloride
Formula Molekul: C28H37ClN4O2S
Bobot Molekul;529.14
Nomer Registri CAS;367514-88-3

Waca liyaneKirim Pitakonan
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept